CA
RVMD icon

Cliff Asness’s Revolution Medicines RVMD Stock Holding History

Cliff Asness’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243M Buy
1,295,450
+1,178,663
+1,009% +$172M 0.08% 330
2026
Q1 		$11.4M Sell
116,787
-10,383
-8% -$1.05M 0.01% 1279
2025
Q4 		$10.1M Buy
127,170
+56,881
+81% +$3.73M 0.01% 1209
2025
Q3 		$3.24M Buy
70,289
+55,273
+368% +$2.16M ﹤0.01% 1697
2025
Q2 		$552K Buy
15,016
+2,875
+24% +$110K ﹤0.01% 2565
2025
Q1 		$429K Sell
12,141
-3,412
-22% -$138K ﹤0.01% 2515
2024
Q4 		$680K Buy
15,553
+306
+2% +$15.4K ﹤0.01% 2096
2024
Q3 		$691K Buy
15,247
+2,415
+19% +$105K ﹤0.01% 2030
2024
Q2 		$498K Buy
+12,832
New +$480K ﹤0.01% 2058
2024
Q1 		– Sell
-19,985
Closed -$573K – 2490
2023
Q4 		$573K Buy
19,985
+10,384
+108% +$250K ﹤0.01% 1826
2023
Q3 		$266K Buy
+9,601
New +$285K ﹤0.01% 2046

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Cliff Asness's RVMD Position: Q2 2026 in Review

Cliff Asness increased its Revolution Medicines (RVMD) stake by 1,009% in Q2 2026, buying an estimated $172M and bringing the position to 1,295,450 shares worth $243M. The position accounts for 0.08% of the portfolio, ranked #330.

Cliff Asness first reported a position in RVMD in Q3 2023 and has held it in 11 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Cliff Asness held 1,295,450 shares of Revolution Medicines worth $243M as of Q2 2026.
  • Cliff Asness bought 1,178,663 Revolution Medicines shares in Q2 2026, an estimated $172M.
  • Revolution Medicines made up 0.08% of Cliff Asness's portfolio in Q2 2026, its #330 holding.
  • Cliff Asness first reported a position in Revolution Medicines in Q3 2023 and has held it in 11 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.